Brief: Universal Biosensors Sees Better 2023 Sales Performance From Coagulation Unit
05/02/2023 22:06
Feb 6 (Reuters) - Universal Biosensors UBI.AX :
* LOOKING FORWARD TO MUCH BETTER SALES PERFORMANCE FROM
COAGULATION BUSINESS DURING 2023
Source text for Eikon: ID:nASX8sHK78
Further company coverage: UBI.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Universal Biosensors
See all newsBrief: Universal Biosensors Seeks Trading Halt Pending Announcement On Financial Position & Funding
Brief: Universal Biosensors Signs Non-Binding Term Sheet For A$8.5M Funding
Brief: Universal Biosensors Seeks Trading Halt
Brief: Universal Biosensors Inc Posts Qtrly Total Revenue A$1.6 Million
Brief: Universal Biosensors Says John Sharman Steps Down As Managing Director And CEO